{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T06:41:44Z","timestamp":1663310504495},"reference-count":0,"publisher":"European Centre for Disease Control and Prevention (ECDC)","issue":"38","license":[{"start":{"date-parts":[[2010,9,23]],"date-time":"2010-09-23T00:00:00Z","timestamp":1285200000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,9,23]]},"DOI":"10.2807\/ese.15.38.19670-en","type":"journal-article","created":{"date-parts":[[2017,10,4]],"date-time":"2017-10-04T10:08:07Z","timestamp":1507111687000},"update-policy":"http:\/\/dx.doi.org\/10.2807\/1560-7917.es.crp2020","source":"Crossref","is-referenced-by-count":3,"title":["European Medicines Agency updates on the review of Pandemrix and reports of narcolepsy"],"prefix":"10.2807","volume":"15","author":[{"family":"Eurosurveillance editorial team","sequence":"first","affiliation":[{"name":"European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7995","container-title":["Eurosurveillance"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T13:16:35Z","timestamp":1663247795000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurosurveillance.org\/content\/10.2807\/ese.15.38.19670-en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,23]]},"references-count":0,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2010,9,23]]}},"URL":"https:\/\/doi.org\/10.2807\/ese.15.38.19670-en","relation":{},"ISSN":["1560-7917"],"issn-type":[{"value":"1560-7917","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9,23]]}}}